AxoGen's GAAP loss for the 3 months of 2022 was $11.475 million, up 72.3% from $6.66 million in the prior year. Revenue decreased 0.1% to $31.007 million from $31.037 million a year earlier.
AxoGen's GAAP loss for the 3 months of 2022 was $11.475 million, up 72.3% from $6.66 million in the prior year. Revenue decreased 0.1% to $31.007 million from $31.037 million a year earlier. 
ir.axogeninc.com
English (US) 